학술논문
Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals
Document Type
Article
Author
Source
In: European Journal of Drug Metabolism and Pharmacokinetics . (European Journal of Drug Metabolism and Pharmacokinetics, May 2022, 47(3):419-429)
Subject
Language
English
ISSN
21070180
03787966
03787966